Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123712304 | 12371230 | 4 | F | 20160628 | 20160516 | 20160726 | PER | US-PFIZER INC-2016250245 | PFIZER | 43.00 | YR | M | Y | 0.00000 | 20160726 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123712304 | 12371230 | 1 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK | U | 0 | ||||||||||
| 123712304 | 12371230 | 2 | PS | DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | UNK | U | 50467 | ||||||||||
| 123712304 | 12371230 | 3 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | UNK | U | 71484 | ||||||||||
| 123712304 | 12371230 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123712304 | 12371230 | 1 | Neoplasm malignant |
| 123712304 | 12371230 | 2 | Neoplasm malignant |
| 123712304 | 12371230 | 3 | Neoplasm malignant |
| 123712304 | 12371230 | 4 | Neoplasm malignant |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123712304 | 12371230 | Disease progression | |
| 123712304 | 12371230 | Neoplasm malignant |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |